Clonality of HTLV-2 in Natural Infection

PLoS Pathogens

Volumn 10, Issue 3, 2014, Pages

  Melamed, Anat ^a   Witkover, Aviva D ^a   Laydon, Daniel J ^a   Brown, Rachael ^a   Ladell, Kristin ^b   Miners, Kelly ^b   Rowan, Aileen G ^a   Gormley, Niall ^c   Price, David A ^b   Taylor, Graham P ^a   Murphy, Edward L ^d   Bangham, Charles R M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c Illumina   (United Kingdom)

^d BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN;

ARTICLE; BIOINFORMATICS; CD8+ T LYMPHOCYTE; CELL CLONE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLONAL VARIATION; DNA EXTRACTION; DNA INTEGRATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC ASSOCIATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LYMPHOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PROVIRUS; VIRUS GENOME; VIRUS LOAD; VIRUS TRANSFORMATION;

CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; COMPUTATIONAL BIOLOGY; FLOW CYTOMETRY; HIGH-THROUGHPUT SCREENING ASSAYS; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; PROVIRUSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL LOAD; VIRUS INTEGRATION;

EID: 84897448280     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004006     Document Type: Article

References (56)

1. Salemi M, Desmyter J, Vandamme AM, (2000) Tempo and mode of human and simian T-lymphotropic virus (HTLV/STLV) evolution revealed by analyses of full-genome sequences. Mol Biol Evol 17: 374-386.
2. Akagi T, Shimotohno K, (1993) Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. J Virol 67: 1211-1217.
3. Ross TM, Pettiford SM, Green PL, (1996) The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes. J Virol 70: 5194-5202.
4. Roucoux DF, Murphy EL, (2004) The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev 6: 144-154.
5. Gessain A, Cassar O, (2012) Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol 3: 388.
6. Orland JR, Engstrom J, Fridey J, Sacher RA, Smith JW, et al. (2003) Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 61: 1588-1594.
7. Biswas HH, Engstrom JW, Kaidarova Z, Garratty G, Gibble JW, et al. (2009) Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy. Neurology 73: 781-789.
8. Araujo A, Hall WW, (2004) Human T-lymphotropic virus type II and neurological disease. Ann Neurol 56: 10-19.
9. Biswas HH, Kaidarova Z, Garratty G, Gibble JW, Newman BH, et al. (2010) Increased all-cause and cancer mortality in HTLV-II infection. J Acquir Immune Defic Syndr 54: 290-296.
10. Bartman MT, Kaidarova Z, Hirschkorn D, Sacher RA, Fridey J, et al. (2008) Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood 112: 3995-4002.
11. Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, et al. (2003) The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115: 449-459.
12. Ijichi S, Ramundo MB, Takahashi H, Hall WW, (1992) In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II). J Exp Med 176: 293-296.
13. Lal RB, Owen SM, Rudolph DL, Dawson C, Prince H, (1995) In vivo cellular tropism of human T-lymphotropic virus type II is not restricted to CD8+ cells. Virology 210: 441-447.
14. Jones KS, Fugo K, Petrow-Sadowski C, Huang Y, Bertolette DC, et al. (2006) Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J Virol 80: 8291-8302.
15. Kannian P, Yin H, Doueiri R, Lairmore MD, Fernandez S, et al. (2012) Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion. J Virol 86: 3757-3766.
16. Chen IS, Quan SG, Golde DW, (1983) Human T-cell leukemia virus type II transforms normal human lymphocytes. Proc Natl Acad Sci U S A 80: 7006-7009.
17. Tarsis SL, Yu MT, Parks ES, Persaud D, Munoz JL, et al. (1998) Human T-lymphocyte transformation with human T-cell lymphotropic virus type 2. J Virol 72: 841-846.
18. Furukawa Y, Fujisawa J, Osame M, Toita M, Sonoda S, et al. (1992) Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-1-associated myelopathy (HAM-TSP). Blood 80: 1012-1016.
19. Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S, (1995) Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 69: 2863-2868.
20. Cimarelli A, Duclos CA, Gessain A, Casoli C, Bertazzoni U, (1996) Clonal expansion of human T-cell leukemia virus type II in patients with high proviral load. Virology 223: 362-364.
21. Gabet AS, Moules V, Sibon D, Nass CC, Mortreux F, et al. (2006) Endemic versus epidemic viral spreads display distinct patterns of HTLV-2b replication. Virology 345: 13-21.
22. Matsuoka M, Jeang KT, (2011) Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 30: 1379-1389.
23. Gillet NA, Malani N, Melamed A, Gormley N, Carter R, et al. (2011) The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 117: 3113-3122.
24. Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, et al. (2013) Genome-wide Determinants of Proviral Targeting, Clonal Abundance and Expression in Natural HTLV-1 Infection. PLoS Pathog 9: e1003271.
25. Wattel E, Cavrois M, Gessain A, Wain-Hobson S, (1996) Clonal expansion of infected cells: a way of life for HTLV-I. J Acquir Immune Defic Syndr Hum Retrovirol 13 Suppl 1: S92-99.
26. Higuchi M, Fujii M, (2009) Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis. Retrovirology 6: 117.
27. Gillet NA, Gutierrez G, Rodriguez SM, de Brogniez A, Renotte N, et al. (2013) Massive Depletion of Bovine Leukemia Virus Proviral Clones Located in Genomic Transcriptionally Active Sites during Primary Infection. PLoS Pathog 9: e1003687.
28. Gillet NA, Cook L, Laydon DJ, Hlela C, Verdonck K, et al. (2013) Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo. PLoS Pathog 9: e1003263.
29. Cook LB, Elemans M, Rowan AG, Asquith B, (2013) HTLV-1: persistence and pathogenesis. Virology 435: 131-140.
30. Gini C (1912) Variabilità e Mutuabilità. Contributo allo Studio delle Distribuzioni e delle Relazioni Statistiche. C. Cuppini, Bologna.
31. Meekings KN, Leipzig J, Bushman FD, Taylor GP, Bangham CR, (2008) HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog 4: e1000027.
32. Sieburg M, Tripp A, Ma JW, Feuer G, (2004) Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis. J Virol 78: 10399-10409.
33. Robek MD, Ratner L, (1999) Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol 73: 4856-4865.
34. Asquith B, Zhang Y, Mosley AJ, de Lara CM, Wallace DL, et al. (2007) In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A 104: 8035-8040.
35. Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, et al. (1989) Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 43: 250-253.
36. Yamaguchi K, Watanabe T, (2002) Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol 76 Suppl 2: 240-245.
37. Tsubata C, Higuchi M, Takahashi M, Oie M, Tanaka Y, et al. (2005) PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein is essential for the interleukin 2 independent growth induction of a T-cell line. Retrovirology 2: 46.
38. Ren T, Dong W, Takahashi Y, Xiang D, Yuan Y, et al. (2012) HTLV-2 Tax immortalizes human CD4+ memory T lymphocytes by oncogenic activation and dysregulation of autophagy. J Biol Chem 287: 34683-34693.
39. Imai M, Higuchi M, Kawamura H, Yoshita M, Takahashi M, et al. (2013) Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells. Virus Genes 46: 39-46.
40. Bangham CR, (2009) CTL quality and the control of human retroviral infections. Eur J Immunol 39: 1700-1712.
41. Bangham CR, Meekings K, Toulza F, Nejmeddine M, Majorovits E, et al. (2009) The immune control of HTLV-1 infection: selection forces and dynamics. Front Biosci 14: 2889-2903.
42. Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, et al. (1991) Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol 3: 761-767.
43. Goon PK, Biancardi A, Fast N, Igakura T, Hanon E, et al. (2004) Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis 189: 2294-2298.
44. Oliveira AL, Hayakawa H, Schor D, Leite AC, Espindola OM, et al. (2009) High frequencies of functionally competent circulating Tax-specific CD8+ T cells in human T lymphotropic virus type 2 infection. J Immunol 183: 2957-2965.
45. Wang TG, Ye J, Lairmore MD, Green PL, (2000) In vitro cellular tropism of human T cell leukemia virus type 2. AIDS Res Hum Retroviruses 16: 1661-1668.
46. Casoli C, Cimarelli A, Bertazzoni U, (1995) Cellular tropism of human T-cell leukemia virus type II is enlarged to B lymphocytes in patients with high proviral load. Virology 206: 1126-1128.
47. Ren T, Cheng H, (2013) Differential transforming activity of the retroviral Tax oncoproteins in human T lymphocytes. Front Microbiol 4: 287.
48. Barbeau B, Peloponese JM, Mesnard JM, (2013) Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis. Front Microbiol 4: 226.
49. Murphy EL, Watanabe K, Nass CC, Ownby H, Williams A, et al. (1999) Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States. J Infect Dis 180: 1777-1783.
50. Kattan T, MacNamara A, Rowan AG, Nose H, Mosley AJ, et al. (2009) The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol 182: 5723-5729.
51. Lee TH, Chafets DM, Busch MP, Murphy EL, (2004) Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J Clin Virol 31: 275-282.
52. Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, et al. (2006) Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis 194: 1557-1564.
53. Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R, et al. (2010) Galaxy: a web-based genome analysis tool for experimentalists. Curr Protoc Mol Biol Chapter 19Unit 19 10 11-21.
54. Goecks J, Nekrutenko A, Taylor J, Galaxy T, (2010) Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 11: R86.
55. Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CR, (2012) HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood 120: 3488-3490.
56. Handcock MS, Morris M (1999) Relative distribution methods in the social sciences. New York: Springer. xiii, 265 p.